Acumen Pharmaceuticals
ABOS
ABOS
61 hedge funds and large institutions have $113M invested in Acumen Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
27% less call options, than puts
Call options by funds: $206K | Put options by funds: $284K
29% less capital invested
Capital invested by funds: $158M → $113M (-$45.2M)
Holders
61
Holding in Top 10
3
Calls
$206K
Puts
$284K
Top Buyers
| 1 | +$742K | |
| 2 | +$548K | |
| 3 | +$475K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$271K |
| 5 |
Jane Street
New York
|
+$261K |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$1.92M | |
| 3 | -$1.88M | |
| 4 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$690K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$602K |